◆ About

One-of-a-kind, since 1986.

§ 01
Origins

The Weinstein / ICDAR Conference originated from a series of annual meetings in which investigators funded by three separate RFAs on Cardiac Development in 1986, 1988, and 1990 came together under the direction of Dr. Constance Weinstein and colleagues at the NHLBI.

Since its inception, the 3-day Weinstein meeting has become the premier venue for basic and clinical researchers in cardiovascular development and regeneration to interact and present innovative new data on traditional and emerging topics in the field.

§ 02 — Why one of a kind

Three reasons.

01
Freestanding

A freestanding conference organized by rotating local and international committees.

02
Trainee-first

Attended by senior leaders in cardiovascular biology, while placing strong emphasis on giving a platform to junior investigators and trainees through talks and posters.

03
Collaborative

Its collaborative, collegial environment encourages the dissemination of new, often unpublished data, enhancing the scientific impact of the meeting.

§ 03 — Organizing Committee

Local Organizing Committee.

Prof. Dr. Didier Stainier
Max Planck Institute for Heart and Lung Research, Bad Nauheim
Prof. Dr. Didier Stainier
Director, Department of Developmental Genetics
Prof. Dr. Thomas Braun
Max Planck Institute for Heart and Lung Research, Bad Nauheim
Prof. Dr. Thomas Braun
Director, Department of Cardiac Development and Remodelling
Prof. Dr. Stefanie Dimmeler
Goethe University Frankfurt
Prof. Dr. Stefanie Dimmeler
Director, Institute for Cardiovascular Regeneration
Prof. Antonio Baldini
University of Naples Federico II
Prof. Antonio Baldini
Full Professor, Dept. of Molecular Medicine and Medical Biotechnology
Prof. Karina Yaniv
Weizmann Institute of Science / HI-TAC Mannheim
Prof. Karina Yaniv
Principal Investigator, Vascular and Lymphatic Biology; Scientific Director, HI-TAC
§ 04 — Partners

Supported by.

The Weinstein Conference 2027 is organized together with partner universities and research consortia from the cardiovascular research community.

To be announced
PARTNER LOGOS WILL APPEAR HERE